http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113373222-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_362de3672be8d6ca22602554017f0678 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-154 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57438 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-543 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-686 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6869 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-686 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6869 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2021-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8572bf700113d99220a2b4f072f8008 |
| publicationDate | 2021-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-113373222-A |
| titleOfInvention | Early screening evaluation method for pancreatic ductal adenocarcinoma |
| abstract | The invention discloses an early screening evaluation method for pancreatic ductal adenocarcinoma, which comprises the following operation steps: s1: selecting 100 early pancreatic ductal adenocarcinoma (stage I or II) population and 900 healthy population as test detection objects, extracting 10 ml of venous whole blood of the detection objects, removing blood cells by adopting a centrifugation method to obtain serum, and collecting by adopting a common blood collection tube containing Ethylene Diamine Tetraacetic Acid (EDTA) if the object is centrifuged in a central laboratory for 4 hours. The early-screening evaluation method for the ductal adenocarcinoma of the pancreas provided by the invention judges the risk degree of the ductal adenocarcinoma of the Pancreas (PDAC) by utilizing the multidimensional detection of protein and DNA in blood, can be applied to healthy people, is earlier than the average 8 months of the traditional detection method, finds the ductal adenocarcinoma of the Pancreas (PDAC) earlier, and can also be used for dynamically monitoring the disease development of patients with the ductal adenocarcinoma of the pancreas in treatment, thereby bringing better use prospects. |
| priorityDate | 2021-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 47.